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Understanding how the environments we are exposed to influence the
diseases we contract and the severity of those diseases is a major goal of
the National Institute of Environmental Health Sciences (NIEHS).
Although much effort has focused on the gene–environment axis,
there is a growing body of information that suggests that environ-
mental influences may extend beyond the DNA sequences of our
genes. The recent completion of sequencing projects for the genomes
of humans and several model organisms has provided, for the first
time, a glimpse of the information required for the diversity of
eukaryotic life. The information embedded in the linear nucleotide
sequence of DNA contains coding information for RNA and pro-
tein, as well as regulatory sequences that control the biology of DNA
itself. However, eukaryotic cells contain an additional level of infor-
mation superimposed on the DNA double helix in the form of a
complex nucleoprotein entity generically termed “chromatin.”
Recent studies have highlighted the instructive nature of this “DNA
packaging” in regulating the interactions of the enzymatic machines
of replication, transcription, recombination, and repair with DNA.
The emerging field dedicated to the study of this form of biologic
regulation is termed “epigenetics.” Formally, epigenetics constitutes
the study of changes in gene expression not accompanied by alter-
ations in DNA sequence. In a more practical sense, epigenetics
includes the study of the protein constituents of chromatin, the
interaction of microRNAs with the genome, and the protein and
DNA modifications that appear to define biologic states in local
regions of chromosomes.
The field of epigenetics has existed for decades, springing from
genetic studies of the phenotypic variability of diverse biologic read-
outs such as eye color in Drosophila (Muller 1930; Schultz 1950),
mating cassette silencing in yeast (Hawthorn 1963), and X chromo-
some inactivation in mammals (Lyon 1961). These early genetic
studies resulted in the establishment of functional relationships
among various factors in regulation of gene expression through analy-
sis of their genetic interactions. Biochemical identification and char-
acterization of enzymatic machinery responsible for DNA
modification (Bestor et al. 1988; Okano et al. 1998) and histone
modification patterns (Brownell et al. 1996; Taunton et al. 1996) in
the 1980s and 1990s led to a greater appreciation of the underlying
biochemical principles of epigenetic regulation (Fischle et al. 2003;
Rea et al. 2000). These studies relied heavily on prior genetic data
and provided mechanistic insight into how genetic modifiers of eye
color variegation, for example, regulate gene expression (Fischle et al.
2003; Rea et al. 2000). 
A unifying concept central to a modern, molecular view of epi-
genetics postulates that the pattern of modifications (both of DNA
and of histone proteins themselves) provides information content
that instructs the enzymes integral to nuclear physiology (Jaenisch
and Bird 2003; Strahl and Allis 2000). Importantly, although
chromosomes are dynamic organelles, the epigenetic information can
be quite stable, surviving multiple rounds of mitotic cell division
(Cavalli and Paro 1998), meiosis (Cavalli and Paro 1998), or even
nuclear transfer (Ng and Gurdon 2005). In a sense, the chromosome
contains two intertwined types of information: the linear sequence of
nucleotide bases in DNA codes for biologic macromolecules, and the
regulatory information embedded in the nucleoprotein architecture
of chromatin specifies which regions of the genome are active in any
given cell. Epigenetic
regulation is a pri-
mary driving force
behind the creation
of different cell types,
each with the DNA
sequence, during de-
velopment of multi-
cellular organisms. A
seminal finding that
monozygotic twins
are epigenetically
indistinguishable early in life but, with age, exhibit substantial differ-
ences in epigenetic markers underscores the important role played by
the environment in shaping the epigenome (Fraga et al. 2005). 
Given the importance of epigenetic regulation to normal nuclear
function, it is pertinent to ask whether alterations in this form of
regulation might impact disease. Components of the epigenetic
machinery, in fact, are altered in various human diseases including
neurologic disorders (e.g., Rett syndrome and α-thalassemia X-linked
mental retardation), congenital malformation (e.g., Rubinstein Taybi
syndrome), immune disorders (e.g., ICF syndrome), and even aging.
Epigenetic alterations also constitute the molecular basis of pathology
associated with loss of imprinting (e.g., Prader-Willi, Angelman, and
Beckwith-Weidemann syndromes). Moreover, there are multiple
connections between epigenetic errors and neoplasia including altera-
tions in genomic DNA methylation (Ballestar and Esteller 2005) and
histone acetylation patterns (Ballestar and Esteller 2005; Slany 2005).
The current excitement over epigenetics and its potential as a tool
for diagnosis and treatment of human disease seems warranted.
However, there are still important knowledge gaps in the field. The
solution of the structure of DNA by Watson and Crick in the 1950s
(Watson and Crick 1953) immediately suggested a mechanism—
semiconservative replication—by which the genetic material could be
faithfully transmitted from one generation to the next. A major
dilemma for the field of epigenetics concerns how the regulatory
information embedded in the protein constituents of chromatin is
replicated during S phase. Identification of the mechanisms involved
in faithfully copying the epigenetic information will represent an
important conceptual advance. Additionally, we do not currently
understand the “language” of epigenetics. Deciphering the genetic
code revealed the language used by DNA to propagate information.
The current state-of-the-art translation of epigenetic cues is both
crude and limited in scope. Despite the considerable progress made
in this area over the past decade, scientists are only beginning to deci-
pher the information embedded in chromatin. The alphabet of epige-
netics is not completely described and, importantly, the mechanism
by which cells read and interpret this information is also largely
unknown. 
Epigenetic information promises to serve as an important adjunct
to DNA sequence in the analysis of biologic response to environmen-
tal exposures. Obviously, biologic parameters that contribute to the
functionality of DNA will be affected by exposure in much the same
manner as DNA sequence (by mutation). A major difference between
epigenetic and genetic outcomes is that while DNA sequence is static,
the epigenome is a dynamic entity that changes with cell type, during
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environmental changes. Deciphering how the epigenome responds to
environmental exposures and how it predicts disease risk holds great
promise and will undoubtedly prove an important adjunct to muta-
tional analyses. Recently, multiple reports have linked epigenetic
mechanisms to the phenotypic effects of environmental exposures
during critical periods of development (Anway et al. 2005). In real
human terms, these exposures result from such variable behaviors as
nutrition and lifestyle. Some of these may have a direct influence on
embryonic development, whereas others may exert their effects later
in life, as predicted by the Barker hypothesis (Barker 1990).
Although current understanding of epigenetics lags behind our
more fundamental understanding of the information content in
DNA sequence, the epigenome will undoubtedly serve as a thera-
peutic target in the future. In fact, epigenetic therapies are cur-
rently under investigation in diverse diseases including cancer,
sickle cell anemia, and thalassemias (de Vos 2005). Personalized
medicine will certainly be affected by epigenetic differences
between individuals and the contributions of this epigenetic poly-
morphism to disease onset, severity, and outcome. The seemingly
limitless potential applications to problems relevant to human
health and disease underscore the need to elucidate the basic prin-
ciples of epigenetic regulation at a molecular level. Understanding
the mechanistic basis of how epigenetic regulation is achieved is
fundamental to placing this level of biologic regulation in the tool
box of environmental health science and medicine. 
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